Do you know the role Medical Science Liaisons can have when introducing a new drug to market? Firstly, they can help you achieve a faster uptake of your drug. Deploying MSLs during the pre-launch phase and before product approval can help prepare the market and drive evidence-based decision-making, reach key decision makers and KOLs, while educating them on the value that your product will bring.
Understanding the Chronic Disease Patient Journey in Emerging Markets
Thursday, May 12th 2016, 11:00am EDT
Register now and join market research consultants Marc Yates and Rachel Howard for this complimentary webinar in which they will explore the chronic disease patient journey in emerging markets. Utilising local knowledge and detailed case studies, they will examine the patient journey from origination through to presentation, diagnosis, treatment choice, follow up and compliance and outline both the opportunities and challenges for global pharma at each stage.
Speed to Insight: Four Strategies You Need to Maximize the Value of Your Data Assets
Recorded on February 23, 2016
Join Hewlett Packard Enterprise and Linguamatics as they discuss the right questions to ask about your company’s analytics capabilities to gain a competitive advantage.
New Tufts CSDD Research: Industry Adoption of eClinical Standards
Recorded on October 8, 2015
This webcast will review new findings from a recent Tufts CSDD working group covering adoption rates of eClinical tools and CDISC standards among 296 sponsors and 146 CROs. Our expert panel of industry speakers will explore the reasons behind wide disparities in adoption, benefits they are currently gaining from eClinical tool and standards, and the quality, safety, and efficiency benefits they expect to gain from increased usage.
The Growing Aging Consumer Population – Living Longer, Living Smarter
Recorded on October 12, 2015
Advanced, Innovative Technologies to Address the Specific Needs of an Aging Population. Featuring, Stephen Tindal, Director of Scientific Affairs, Catalent Softgel Research & Development and Monica Feldman, Head of Industry Research, Consumer Health for Euromonitor International Inc.
Patient Adherence in Germany - Benefit vs. Cost-Containment
Recorded on June 24, 2015
Join Joanne Thiele, Market Access Project Manager from Quintiles Germany and Hans Holger Bleß, Director of Health Services Research department at IGES Institut GmbH as they discuss the importance of patient adherence programs in Germany.
Breaking Through the Complexity: Improving Oncology Treatment and Acces in the UK
Recorded on June 30, 2015
Join Dean Summerfield, Senior Vice President, Commercial and Consulting from Quintiles and Dr Jason Lester, Consultant Clinical Oncologist at the Velindre Cancer Centre as they discuss improving innovative oncology treatment and access in the UK
On the Road to Integration: Moving Your Multichannel Program into the Fast Lane
Recorded on July 1, 2015
Join Peter Lammers and Liz Murray from Quintiles as they present insightful research findings regarding the state of the pharmaceutical industry and the use of multi-channel marketing strategies. Learn what other industries apply successfully and get different options for you to actually “make it happen” for your product.
No Access, No business: The rocky road to Market Access Excellence
Recorded on September 1, 2015
Market Access needs to be the most important function in your organization. Transforming this function to fulfill that key role is difficult, but possible. Learn in our webcast how to achieve true Excellence in Market Access and be ready for future challenges.
Embedding Patient Centricity - Understanding the role of real-world evidence in global market access strategies
Recorded on April 28, 2015
Join Dr Louise Parmenter and Dr Stella Blackburn from Qunitiles as they discuss the importance of embedding patient centricity into the development of real-world evidence in global market access strategies.